In a study appearing in the September 13 issue of JAMA, Jouke T. Annema, M.D., Ph.D., of the Academic Medical Center, Amsterdam, and colleagues examined five-year survival…

In the Age of Personalized Medicine, we’ve learned that one size doesn’t fit all, least of all in cancer. Cancer is a disease of your…

New Haven, Conn. -Most patients with non-small cell lung cancer (NSCLC) that has metastasized to the brain have a dire prognosis. But Yale researchers have…

The proportion of lung cancer patients who never smoked more than doubled from 2008 to 2014, a British investigator reported here.

Never-smokers accounted for 13% of non-small…

A new drug that blocks cancer’s escape route from chemotherapy could be used to treat deadly lung and pancreatic cancers, new research reports.

Scientists have shown in human…

Researchers estimate that 48.5 percent of the nearly 346,000 deaths from 12 cancers among adults 35 and older in 2011 were attributable to cigarette smoking, according to…

Survival rates for patients with lung cancer increase dramatically the earlier the disease is diagnosed, underscoring the need for effective biomarkers that can be used for detection.…

After identifying three different types of resistance to a promising investigational lung cancer drug in a phase 1 trial, a team of researchers led by Dana-Farber Cancer…

Lung cancer patients who used statins in the year prior to a lung cancer diagnosis or after a lung cancer diagnosis had a reduction in the risk…

Researchers at the University of Louisville have detailed a critical connection associated with a major environmental cause of silicosis and a form of lung cancer. Their…

People with limited education and low income have higher odds of death within 30 days after undergoing an operation for lung cancer than those who…

Researchers at Genes and Cancer group at Bellvitge Biomedical Research Institute (IDIBELL), led by Montse Sanchez-Cespedes, have identified the PARD3 gene as a tumor suppressor that is…

Since November 2014 nintedanib (trade name: Vargatef) has been approved in combination with docetaxel for the treatment of adults with advanced non-small cell lung cancer (NSCLC) of…

The Women’s Health Initiative Studies, a large prospective study of lung cancer, found no strong associations between lung cancer risk and a…

Lung cancer is the second most common type of cancer and the number one cause of cancer-related mortality. It is estimated that more than 158,000…

The German Lung Cancer Screening Intervention Trial (LUSI) shows that the early repeat scan rate for suspicious findings decreased by more than 80% with the second…

Nanoparticles are extremely small particles that can be modified for a variety of uses in the medical field. For example, nanoparticles can be engineered to be able to transport medicines specifically to…

An analysis of lung cancer incidence and screening found a decline in the proportion of patients with lung cancer meeting high-risk screening criteria, suggesting that an increasing…

New research from Johns Hopkins School of Medicine reveals a high value of scans which could lead to future change of reimbursement policies for follow-up…

U.S. health regulators on Thursday approved Medicare coverage for lung cancer screening by low-dose CT, the first time the government health insurance program for the elderly and disabled will…

A new analysis led by researchers at the American Cancer Society in collaboration with the International Agency for Research on Cancer (IARC) finds lung…

Adding head and neck cancer screenings to recommended lung cancer screenings would likely improve early detection and survival, according to a multidisciplinary team led…

CANCER RESEARCH UK scientists have taken microscopic images revealing that the protein ties tethering cells together are severed in lung cancer cells - meaning they can break loose and…

University of Cincinnati researchers have found in a phase-2 clinical trial that a Food and Drug Administration-approved therapy could be effective in treating both older and African…

A new study shows that patients with stage I to stage III non-small cell lung cancer have different metabolite profiles in their blood than those…